Concomitant B.I.D. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study11Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) was the promoter of this study.22Presented at the 39th annual ASTRO meeting, Orlando, October 19

Concomitant B.I.D. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study11Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) was the promoter of this study.22Presented at the 39th annual ASTRO meeting, Orlando, October 19–23, 1997.

Published:1998-09 Issue:2 Volume:42 Page:237-245
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Bensadoun René-Jean,Etienne Marie-Christine,Dassonville Olivier,Chauvel Pierre,Pivot Xavier,Marcy Pierre-Yves,Prevost Bernard,Coche-Dequeant Bernard,Bourdin Sylvain,Vallicioni Jacques,Poissonnet Gilles,Courdi Adel,Teissier Eric,Lagrange Jean-Léon,Thyss A,Santini José,Demard François,Schneider Maurice,Milano Gérard

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference76 articles.

1. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma;Pinto;Int J Radiat Oncol Biol Phys,1991

2. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma;Horiot;Radiother Oncol,1992

3. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck;Parsons;Head Neck,1993

4. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of head and neck;Kish;Cancer Treat Rep,1982

5. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120 hour 5-FU infusion and cisplatin;Rooney;Cancer,1985

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International consensus (ICON) on assessment of oropharyngeal dysphagia;European Annals of Otorhinolaryngology, Head and Neck Diseases;2018-02

2. Exclusive concurrent radiochemotherapy for advanced head and neck cancers with ‘fractionated’ 5-fluorouracil and cisplatin;Anti-Cancer Drugs;2017-02

3. An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancera);Medical Physics;2012-08-02

4. Tobacco Use in Human Papillomavirus-Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence;Clinical Cancer Research;2010-02-09

5. Individualization of 5-Fluorouracil in the Treatment of Colorectal Cancer;SRX Pharmacology;2010